Hims & Hers shares drop 7% premarket on wider Q2 loss

Shares of Hims & Hers Health Inc. fell 7% in premarket trading on Thursday after the telehealth company reported a wider-than-expected second-quarter loss despite a 38% revenue increase.

The company, which provides online medical and wellness services, posted a net loss of $34.5 million for the quarter ended June 30, compared with a loss of $22.1 million in the same period last year. Analysts had expected a loss of $28.7 million, according to Refinitiv data.

Revenue rose to $230.6 million from $167.1 million a year earlier, exceeding the $220.5 million forecast. The growth was driven by increased demand for its mental health, sexual health, and weight loss services, the company said.

Hims & Hers also raised its full-year 2026 revenue guidance to a range of $1.2 billion to $1.3 billion, up from its prior estimate of $1.1 billion to $1.2 billion. The company attributed the upward revision to strong customer retention and expansion in its core service lines.

Despite the improved revenue outlook, the stock’s premarket decline reflected investor concern over the deeper-than-expected losses, which the company attributed to higher marketing and operational costs as it scales its business.

Hims & Hers shares were trading at $12.45 in premarket activity, down from Wednesday’s close of $13.38.